Register here

On Friday June 28 at 1:30 PM PT, join the Center on Reproductive Health, Law, and Policy, legal scholars, impacted providers, abortion researchers, and advocates to discuss the practical effects of FDA v. Alliance for Hippocratic Medicine, concerning access to mifepristone, and Moyle v. United States, concerning whether EMTALA supersedes Idaho’s abortion ban. We will discuss how these cases impact access to abortion across the country.

Speakers currently include (subject to minor changes): 

Moderator: Melissa Goodman JD, Executive Director at the Center on Reproductive Health, Law, and Policy

• Cary Franklin JD, McDonald/Wright Chair of Law & Faculty Director of the Center on Reproductive Health, Law, and Policy
• Ushma Upadhyay, PhD, MPH, Professor, Dept. of Obstetrics, Gynecology, and Reproductive Sciences UCSF & Co-Director, UCGHI Center for Gender and Health Justice,  Advancing New Standards in Reproductive Health (ANSIRH) 
• Kylie Cooper, MD, Maternal-Fetal Medicine Specialist, Mayo Clinic
• Caitlin Gustafson, MD Physician, Co-President, Idaho Coalition for Safe Healthcare